Lan-demets Alpha-spending

Lan-DeMets Alpha-Spending is a sequential monitoring boundary method in group-sequential clinical trials that allocates the overall Type I error rate across interim analyses according to a prespecified alpha-spending function derived from Lan and DeMets' stochastic curtailment approach, thereby maintaining trial validity while allowing flexible timing of interim looks.

9

Publications

335

Citations

45

Authors

37

Institutions

Publications per year

2017–2026

0

Authors

45

  1. KK
    K. K. Gordon Lan

    National Heart Lung and Blood Institute, United States

    1 publications · 126 citations

    1

    h-index

  2. JP
    J.M. Piulats Rodriguez

    Institut Català d'Oncologia, Spain

    1 publications · 58 citations

    1

    h-index

  3. DL
    David L. DeMets

    University of Wisconsin–Madison, United States

    1 publications · 126 citations

    1

    h-index

  4. EJ
    Eric J. Small

    University of California, San Francisco, United States

    1 publications · 58 citations

    1

    h-index

  5. KF
    Karim Fizazi

    Institut Gustave Roussy, France

    1 publications · 58 citations

    1

    h-index

1–5 of 45

Venues

  1. Statistics in Medicine

    3 publications · 60 citations

    3

    h-index

  2. Controlled Clinical Trials

    1 publications · 126 citations

    1

    h-index

  3. Biometrics

    1 publications · 27 citations

    1

    h-index

  4. Cancer Research

    1 publications · 18 citations

    1

    h-index

  5. Journal of Clinical Oncology

    1 publications · 58 citations

    1

    h-index

1–5